These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 8494575)
1. Disposition of a new heparan sulfate with fibrinolytic activity in the rat. Gervasi GB; Farina C; Bartoli C; Catalani R; Carpita G; Pistelli N Arzneimittelforschung; 1993 Apr; 43(4):445-9. PubMed ID: 8494575 [TBL] [Abstract][Full Text] [Related]
2. Tissue distribution and antithrombotic activity of unlabeled or 14C-labeled porcine intestinal mucosal heparin following administration to rats by the oral route. Hiebert LM; Wice SM; Ping T; Hileman RE; Capila I; Linhardt RJ Can J Physiol Pharmacol; 2000 Apr; 78(4):307-20. PubMed ID: 10772058 [TBL] [Abstract][Full Text] [Related]
3. Fucosylated chondroitin sulfate as a new oral antithrombotic agent. Fonseca RJ; Mourão PA Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379 [TBL] [Abstract][Full Text] [Related]
4. Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats. Costantini V; Deveglia R; Stabile A; Nenci GG Blood Coagul Fibrinolysis; 2000 Jan; 11(1):7-13. PubMed ID: 10691095 [TBL] [Abstract][Full Text] [Related]
5. Evidence for the absorption of heparin by rat stomach. Hiebert LM; Wice SM; Abdelhameed T Biomed Pharmacother; 2007 Jan; 61(1):68-74. PubMed ID: 17196786 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic efficacy in a rat model of the low molecular weight heparin, reviparin sodium, administered by the oral route. Hiebert LM; Wice SM; Ping T; Herr D; Laux V Thromb Haemost; 2001 Jan; 85(1):114-8. PubMed ID: 11204561 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
8. Evidence from endothelium of gastric absorption of heparin and of dextran sulfates 8000. Jaques LB; Hiebert LM; Wice SM J Lab Clin Med; 1991 Feb; 117(2):122-30. PubMed ID: 1993853 [TBL] [Abstract][Full Text] [Related]
9. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
10. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes. Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451 [TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
13. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans. Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130 [TBL] [Abstract][Full Text] [Related]
14. Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats. Van Ommen B; De Bie AT; Bär A Regul Toxicol Pharmacol; 2004 Jun; 39 Suppl 1():57-66. PubMed ID: 15265616 [TBL] [Abstract][Full Text] [Related]
15. Analysis and prediction of absorption profile including hepatic first-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, after oral ingestion in rats by gastrointestinal-transit-absorption model. Kimura T; Iwasaki N; Yokoe JI; Haruta S; Yokoo Y; Ogawara KI; Higaki K Drug Metab Dispos; 2000 May; 28(5):577-81. PubMed ID: 10772638 [TBL] [Abstract][Full Text] [Related]
16. An in vitro study with an ussing chamber showing that unfractionated heparin crosses rat gastric mucosa. Moazed B; Hiebert LM J Pharmacol Exp Ther; 2007 Jul; 322(1):299-305. PubMed ID: 17435109 [TBL] [Abstract][Full Text] [Related]
17. In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats. Koudriakova T; Iatsimirskaia E; Tulebaev S; Spetie D; Utkin I; Mullet D; Thompson T; Vouros P; Gerber N J Pharmacol Exp Ther; 1996 Dec; 279(3):1300-9. PubMed ID: 8968354 [TBL] [Abstract][Full Text] [Related]
18. Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats. De Bie AT; Van Ommen B; Bär A Regul Toxicol Pharmacol; 1998 Apr; 27(2):150-8. PubMed ID: 9671569 [TBL] [Abstract][Full Text] [Related]
19. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic profile of ITF 296 in rats and dogs. Monzani MV; Coltro G; Jiritano L; Sala A J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S67-71. PubMed ID: 8839229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]